HealthModerna and Merck Announce Breakthrough mRNA Cancer Vaccine That Significantly Reduces Melanoma Spread
Moderna and Merck revealed that their personalised mRNA cancer vaccine, Intismeran, successfully reduced the recurrence and spread of high-risk melanoma in a late-stage clinical trial.
Al Jazeera English|August 19, 2026